Back
Tema Obesity & Cardiometabolic ETF Vs. Fidelity Disruptive Medicine ETF Industry Stock Comparison
Sell
28
HRTS
Tema Obesity & Cardiometabolic ETF
Last Price:
34.50
Seasonality Move:
--
Sell
46
FMED
Fidelity Disruptive Medicine ETF
Last Price:
26.47
Seasonality Move:
1.11%
Sell
28
Tema Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema Obesity & Cardiometabolic ETF a Buy, Sell or Hold?
- The current Tema Obesity & Cardiometabolic ETF [HRTS] share price is $34.68. The Score for HRTS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- HRTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
- The current Fidelity Disruptive Medicine ETF [FMED] share price is $26.36. The Score for FMED is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HRTS Stock Price Chart
What is Tema Obesity & Cardiometabolic ETF's stock price today?
-
The Tema Obesity & Cardiometabolic ETF share price today is $34.68
The current trend is moderately bearish and HRTS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $26.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FMED is experiencing slight selling pressure.
HRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | 16376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.32 - 35.08) | Sell |
| Bollinger Bands (100): | (32.39 - 34.69) | Buy |
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 61.9 | Buy |
| Chaikin Money Flow: | -1334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.61 - 26.21) | Buy |
| Bollinger Bands (100): | (23.87 - 25.53) | Buy |
HRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.72 | Sell |
| 20-day SMA: | 34.72 | Sell |
| 50-day SMA: | 34.4 | Buy |
| 200-day SMA: | 32.67 | Buy |
| 8-day EMA: | 34.75 | Sell |
| 20-day EMA: | 34.61 | Buy |
| 50-day EMA: | 34.26 | Buy |
| 200-day EMA: | 32.54 | Buy |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.25 | Buy |
| 20-day SMA: | 26 | Buy |
| 50-day SMA: | 25.34 | Buy |
| 200-day SMA: | 24.52 | Buy |
| 8-day EMA: | 26.25 | Buy |
| 20-day EMA: | 25.97 | Buy |
| 50-day EMA: | 25.44 | Buy |
| 200-day EMA: | 24.47 | Buy |
Tema Obesity & Cardiometabolic ETF Earnings Growth & HRTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tema Obesity & Cardiometabolic ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fidelity Disruptive Medicine ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||